Retinopathy in Systemic Lupus Increases with Longer Hydroxychloroquine Use
October 29th 2019Hydroxychloroquine retinopathy is more common than previously thought, shows a study published in Arthritis and Rheumatology. Higher dosages and long duration of use is associated with a higher risk of vision loss.
Read More
Anakinra Bests TNF Inhibitors in RA Patients with Type 2 Diabetes
October 18th 2019IL-1 inhibition with anakinra was more effective than TNFi treatment for improving glycemic and inflammatory parameters in patients with rheumatoid arthritis and type 2 diabetes, say researchers writing in PLOS Medicine last month.
Read More
COPD Triples Mortality Risk in RA
October 17th 2019Patients with rheumatoid arthritis have a large comorbidity burden at the time of diagnosis, including chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease, but COPD is a particular concern, say researchers writing in Rheumatology this month.
Read More
Hot Yoga May Lower Blood Pressure
October 16th 2019Hot yoga improved ambulatory blood pressure and reduced mental stress, a correlate of hypertension, in adults with elevated blood pressure and stage I hypertension, according to a study presented at AHA’s Hypertension 2019 Scientific Sessions held in New Orleans last month.
Read More
Total Hip Arthroplasty No Better Than Partial Joint Replacement
October 15th 2019Total hip arthroplasty does not provide a clinically significant improvement over hemiarthroplasty in function and quality of life over 24 months, shows a NEJM study. The incidence of secondary procedures did not differ significantly between the two groups.
Read More
Ixekizumab Bests Adalimumab at 24 Weeks in Psoriatic Arthritic Skin, Joint Symptoms
October 10th 2019Ixekizumab was superior to adalimumab at 24 weeks in a head-to-head trial evaluating both skin and joint symptoms in patients with psoriatic arthritis and inadequate response to csDMARDs, say researchers writing in Annals of the Rheumatic Diseases last month.
Read More
Secondary Sjögren’s Syndrome in Lupus Increases with Age
October 7th 2019Sjögren’s syndrome secondary to systemic lupus erythematosus (SLE) rises in frequency with age, affects around one-quarter of all people with systemic lupus, and, despite less internal organ involvement than in systemic lupus without Sjögren’s syndrome, is marked by a systemic inflammatory state with high levels of pro-inflammatory cytokines, say researchers writing in The Journal of Rheumatology this month.
Read More
Parenteral More Efficient than Oral Methotrexate in Rheumatoid Arthritis
October 7th 2019Parenteral methotrexate therapy is more successful than oral methotrexate in achieving optimal disease activity control in rheumatoid arthritis, with no increased adverse effects, say researchers writing in PLoS One this month.
Read More
Imaging Technique May Lead to Better Diagnoses in Rheumatoid Arthritis
October 2nd 2019Fluorescence optical imaging, which enables visualization of inflammation in the hands in rheumatic joint diseases, correlates with ultrasound as a validated and well-established imaging technique in daily rheumatological practice, say researchers writing in Arthritis Research & Therapy this month.
Read More
Spondyloarthritis Lesions Redefined by Physician Group
October 2nd 2019An international physician group writing in the British journal Annals of the Rheumatic Diseases, has updated recommended parameters that constitute lesions in the sacroiliac joints of patients with spondyloarthritis. The definitions of capsulitis, enthesitis, fat lesion and erosion were revised and new definitions were developed for joint space enhancement, joint space fluid, fat metaplasia in an erosion cavity, ankylosis and bone bud.
Read More
Alcohol Consumption Linked to Spinal Structural Progression in Axial Spondyloarthritis
October 2nd 2019Previously, smoking was the sole known modifiable predictor of spinal structural damage, but now alcohol consumption has been shown to be associated with the progression of spinal structural damage in axial spondyloarthritis―specifically by increasing the odds of syndesmophyte progression over two years.
Read More
Local Heat Lowers Blood Pressure in Supine Hypertension
October 2nd 2019Local heat therapy applied overnight effectively lowers blood pressure in patients with both primary autonomic failure and nocturnal supine hypertension, according to a study presented at AHA’s Hypertension 2019 Scientific Sessions in New Orleans.
Read More
Retinopathy Risk in Lupus Increases With Longer Hydroxychloroquine Use
October 1st 2019The incidence of retinopathy among systemic lupus erythematosus (SLE) patents treated with hydroxychloroquine increased with longer treatment duration, but could be predicted by monitoring blood levels of the drug, say researchers writing in Arthritis & Rheumatology this month.
Read More
FDA Approves New Treatment for Rare Pediatric Vasculitis
October 1st 2019The U.S. Food and Drug Administration has approved rituximab (Rituxan, Genentech) for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children 2 years of age and older in combination with glucocorticoids.
Read More
Cardiovascular Disease in Postmenopausal Women with Metabolic Syndrome
September 26th 2019Postmenopausal women with early rheumatoid arthritis have a metabolic syndrome profile similar to men and should equally be considered high risk for the development of cardiovascular disease, according to Bindee Kuriya M.D, writing in the journal ACR Open Rheumatology.
Read More
New Treatment Option for Systemic Sclerosis-Associated Interstitial Lung Disease
September 19th 2019The U.S. Food and Drug Administration has approved nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) capsules to slow the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD), which is a progressive lung disease that can be debilitating and life-threatening.
Read More
Knee Osteoarthritis Pain Intensity is Gender-Related
September 19th 2019Levels of the biomarker urine C-telopeptide of cross-linked collagen type II (uCTX-II) are independently associated with radiographic severity and pain intensity in knee osteoarthritis, say researchers writing in Arthritis Research & Therapy this month.
Read More
Prevalence of Hypertension in Pregnancy Spikes Over Last Four Decades
September 18th 2019The number of pregnant women who develop hypertension during the first 20 weeks of pregnancy has spiked in the U.S. since 1979, especially among black women, with advanced maternal age contributing to this upward trend, say researchers writing in Hypertension this month.
Read More
NSAIDs May Increase Cardiovascular Disease Risk in Osteoarthritis
September 16th 2019Nonsteroidal anti-inflammatory drug (NSAID) use contributes substantially to the increased risk of cardiovascular disease among patients with osteoarthritis, say researchers writing in Arthritis & Rheumatology last month.
Read More
Riociguat for Systemic Sclerosis Digital Ulcers May Require Longer Treatment
September 12th 2019A proof of concept clinical trial for riociguat (Adempas, Bayer) for patients with systemic sclerosis indicates that longer treatment periods may be necessary to heal digital ulcers. In this trial, the treatment wasn't effective in reducing the number of digital ulcers.
Read More
Thyroid Replacement Therapy May Not Offer Long-Term Protective Benefit in Hypothyroidism
September 11th 2019Normal thyroid stimulating hormone levels don't necessarily stave off all-cause mortality for hypothyroid patients, but adverse outcomes may intensify if levels fall below or above the norm.
Read More